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Background. The prevalence of myocardial ischemia is associated with anxiety. State and
trait anxiety are more common in younger women compared to men, and high anxiety levels
could affect hemodynamic reactivity during cardiac stress testing. The aim is to examine
whether anxiety plays a role in gender differences in patients £ 65 and > 65 years in hemo-
dynamic reactivity and ischemia during cardiac stress testing.
Methods and results. Included were 291 patients (66.8 ± 8.7 years, 45% women) with
suspect ischemia undergoing myocardial perfusion single-photon emission computed tomog-
raphy (MPI-SPECT). Primary outcomes were semi-quantitative summed difference score
(SDS) and summed stress score (SSS), as continuous indicators of myocardial ischemia.
Analyses were stratified by age. Trait anxiety was measured using a validated questionnaire
(GAD-7) and state anxiety using facial expression analyses software. Overall, trait and state
anxiety were not associated with the prevalence of ischemia (N = 107, 36%). A significant
interaction was found between gender and trait anxiety in women £ 65 years for SDS
(F(1,4) = 5.73, P = .019) and SSS (F(1,10) = 6.50, P = .012). This was not found for state anx-
iety.
Conclusion. SDS and SSS were significantly higher in women younger than 65 years with
high trait anxiety. This interaction was not found in men and women over 65 years. (J Nucl
Cardiol 2020)
Key Words: Age Æ Cardiac stress testing Æ Myocardial ischemia Æ Sex differences Æ Trait
anxiety
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Abbreviations
CAD Coronary artery disease
HRR Heart rate reserve
LVEF Left ventricular ejection fraction
IHD Ischemic heart disease
MPI Myocardial perfusion imaging
SDS Summed difference score
SRS Summed rest score
SSS Summed stress score
TPD Total perfusion deficit
INTRODUCTION
Traditional cardiovascular risk factors (e.g., smok-
ing, hypertension, and diabetes mellitus) are clinically
important but do not fully account for the gender
differences in the increasing rates of cardiovascular risk
and hospitalizations in younger women.1,2 Large epi-
demiological studies3 and meta-analyses4 have shown
that high levels of psychosocial risk factors are associ-
ated with an increased risk of IHD. Anxiety5 and
depression 6 are among the most prominent psycholog-
ical risk factors for incident ACS and adverse outcomes
in patients with IHD.7 However, depression has been
extensively studied8 and has an official recommendation
in clinical cardiology guidelines.9,10 Anxiety has
received less attention, but multiple studies show its
importance in predicting higher rates of cardiac risk
factors and events.11,12 Findings on anxiety and patients
with suspected myocardial ischemia have been
mixed,13,14 warranting further investigation. The popu-
lation attributable risk of psychological factors for
incident CAD events is found to be higher for women
than men because women report higher levels of
distress-related psychological factors than men.15,16
However, the relative risk of incident CAD events
related to psychological factors does not markedly differ
between women and men.4,17 Specifically, the preva-
lence of anxiety is higher among women compared to
men.18 In addition, especially younger women in the
cardiac patient population (compared to the general
population) have significantly more anxiety-related
problems than older women and men.19 Although
evidence indicates that younger age may be associated
with different pathophysiological processes in women
with IHD,20,21 it is unclear whether the association of
anxiety with inducibility of ischemia is age dependent.
Epidemiological data indicate that women younger
than 65 years of age display increasing rates of acute
coronary syndromes (ACS) relative to men in the same
age range.22,23 Hospitalization and 30-day mortality
rates are also increasing in women younger than
55 years of age compared to men.24 Elevated hemody-
namic reactivity in younger women may partially
explain the relatively high prevalence of myocardial
ischemia in response to adenosine administration during
cardiac stress testing.21 For example, baseline heart rate
and baseline systolic blood pressure (SBP) were signif-
icantly higher in women compared with men during
adenosine cardiac stress testing, and SBP significantly
increased during stress testing for women but not for
men.21 The gender differences in IHD incidence and
progression as well as inducibility of ischemia indicate
that further investigations are needed on the interplay
between gender, age, and cardiovascular risk factors.
High levels of trait anxiety are associated with
higher rates of ischemia in women without a history of
CAD compared to women with lower levels of trait
anxiety.25 Another study showed that, among patients
with non-obstructive CAD, the risk of developing
ischemia during cardiac stress testing was higher among
women with high levels of trait anxiety, but not state
anxiety.26 It has also been documented that trait anxiety
is associated with more frequent and severe cardiac
symptoms.27 The association between anxiety and
ischemia may be accounted for in part by higher
hemodynamic responses during cardiac stress testing.
Anxiety is generally related to increased sympathetic
nervous system activity.28 In addition, elevated levels of
anxiety have been associated with higher sympathetic
nervous system activity in postmenopausal women.29
These data indicate that there may be an interplay
between gender, age, anxiety, and hemodynamic respon-
siveness as related to inducible myocardial ischemia
during cardiac stress testing.
The present study examines whether anxiety plays a
role in the gender differences in hemodynamic reactivity
and inducible ischemia during cardiac stress testing.
Given that evidence suggests that these associations
seem to be stronger in young women, we will also
explore age-stratified analyses. Specifically, it was
hypothesized that: (1) women will report higher levels
of anxiety than men; (2) high levels of anxiety in
patients undergoing cardiac stress testing will be asso-
ciated with elevated hemodynamic reactivity in women,
and less so in men; (3) high levels of anxiety will be
associated with the presence and severity of inducible
ischemia during cardiac stress testing in women, but less
in men. Furthermore, we expect that these gender-
specific associations primarily occur among female
patients of younger age (B 65 years) versus older age
([ 65 years).
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METHODS
Patients
The study sample consisted of 291 patients who under-
went a pharmacological or exercise stress/rest myocardial
perfusion imaging single-photon emission computed tomogra-
phy (MPI-SPECT, henceforth referred to as MPI) protocol
with adenosine (n = 203) (140 mcg-1 kg-1 min-1 for 5
minutes) or exercise (n = 88) (i.e., bicycling to maximum
exertion using the modified Bruce protocol) between January
2017 and December 2018 at Institute Verbeeten Tilburg, the
Netherlands. Inclusion criteria were: (1) referral for the MPI
protocol with adenosine or exercise; (2) ability to fill out
questionnaires; and (3) sufficient knowledge of the Dutch
language. There were no exclusion criteria. Reason for referral
were categorized into ‘examination of new or worsening
symptoms (no previously known CAD)’ (N = 174), ‘exami-
nation of known CAD (returning symptoms)’ (N = 114), or
‘preoperative cardiovascular risk assessment’ (N = 3). All
patients underwent the protocol as described below with MPI
images obtained at rest and following cardiac stress testing.
In order to obtain state anxiety measures, patients’ facial
expressions were video-recorded using a webcam (Logitech
C920-HD Pro) attached to the stationary exercise bicycle, for
both adenosine and exercise stress testing protocols (GE
Healthcare, Ergometer ebike comfort 162202, Freiburg, Ger-
many), as further described below. During cardiac stress
testing (both protocols), patients were asked whether they
experienced anginal chest pain symptoms (anginal chest pain
present/absent) similar to their ‘‘typical’’ cardiac symptoms.
Sociodemographic and psychosocial data were collected
before and after cardiac stress testing. Information on cardio-
vascular risk factors (hypertension, hypercholesterolemia,
familial risk, and smoking), medical history, and medication
was obtained from electronic patient records. In the present
study, we refer to differences between women and men as
gender rather than sex differences, since in human study
participants the contributions of social, environmental, cul-
tural, and behavioral factors and choices cannot be excluded as
factors influencing the research findings.30 The study was
approved by the regional Medical Ethics Committee (METC
Brabant, Protocol number: NL56707.028.16), and all patients
provided written informed consent.
Myocardial Perfusion Imaging (Rest-Stress
Protocol)
All patients underwent a two-day protocol with the first
day allocated to the at-rest imaging and the second day to the
stress (adenosine or exercise) imaging. Patients were instructed
to refrain from consuming caffeine-containing beverages for
24 hours before each protocol day. The first day consisted of
99mTc-tetrofosmin injection (dosage: 370 MBq), and a rest
period of 45 minutes followed by myocardial perfusion
imaging. The second day, patients performed cardiac stress
testing, either pharmacologically by intravenous adenosine
injection (140 mcg-1 kg-1 min-1 for 5 minutes) or by exercise
(i.e., bicycling to maximum exertion using the modified Bruce
protocol). As per standard clinical protocol, the pharmacolog-
ical adenosine cardiac stress testing also involved mild-
intensity cycling to limit adenosine side-effects and reduce
extracardiac activity.31 For the adenosine protocol, 99mTc-
tetrofosmin injection was at 2 minutes after adenosine admin-
istration. During the exercise protocol, the injection was at
peak exercise, at 85% of the maximum heart rate (0.85*(220-
patient age)).
Image acquisition was performed using a hybrid dual-
headed gated IQ SPECT/CT system (Symbia T, Siemens
Medical Solutions AG) equipped with multifocal collimators
(SmartzoomTM) of 128 9 128 matrix size and zoom factor of
1. Acquired data were then reconstructed using an iterative
reconstruction. Attenuation correction was applied using a
patient-dedicated low-dose CT-derived mu map. A symmetric
15% window was centered at 140 keV, with a three-lead
electrocardiographic monitoring. Perfusion images were
inspected by qualified staff before interpretation by experi-
enced observers.
Image Analysis and Hemodynamic
Reactivity Parameters
Bull’s eye generation, and visual analysis using a 17-
segmental model,32 was performed by two experienced
observers. Semi-quantitative analyses of perfusion were per-
formed with QPS software from Cedars-Sinai Medical Center.
The interpretation of the scan was assessed both semiquanti-
tatively and by visual analysis, as is recommended by the
American Society of Nuclear Cardiology (ASNC).33 Both AC
and no-AC images were reviewed during interpretation.
Perfusion was graded on a 0-4 scale: 0 = normal, 1 = equiv-
ocal, 2 = moderate, 3 = severe perfusion defect, and 4 = very
severe perfusion defect. Quantitative summed rest scores
(SRS), summed stress scores (SSS), and summed difference
scores (SDS) were tabulated. Myocardial ischemia was semi-
quantitatively defined as SDS C 2.34 Pixel-wise total perfusion
deficit (TPD) was used as an automated perfusion deficit
parameter and TPD C 3% was considered abnormal and
indicative of a perfusion defect.35
Hemodynamic Reactivity Baseline and peak
heart rate (HR) and blood pressure (BP) were recorded in
beats per minute (bpm) and mmHg, respectively. Peak HR was
defined as the HR at 2 minutes after adenosine injection and
maximum heart rate during the exercise protocol. Peak BP was
recorded at 2 minutes after adenosine injection and at peak
exertion during the exercise protocol. HR response for both
protocols was defined as the % heart rate reserve (HRR, (peak
HR - baseline HR)/baseline HR)*100). Left ventricular
ejection fraction (LVEF) was determined, and also end
diastolic volume (EDV) and end systolic volume (ESV) were
calculated.
Trait Anxiety Measure
The generalized anxiety disorder (GAD)-7 scale is a
clinical screening measure for assessing generalized anxiety
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disorder. The GAD-7 consists of seven items that are answered
on a four-point scale from 0 (‘‘not at all’’) to 3 (‘‘nearly every
day’’). The GAD-7 has been validated in the general popu-
lation,36 yielding a high internal consistency (Cronbach’s alpha
= .89). For analyses, the continuous score of the GAD-7 was
used, with a higher score indicating more anxiety symptoms. A
cut-off score of 10 is also used indicating patients with ‘low
anxiety’ (GAD-7 B 10) and ‘high anxiety’ (GAD-7[ 10).
State Anxiety Measure
Video-Recording State anxiety measures were
based on analyzed video-recordings during cardiac stress
testing for both the adenosine and exercise protocol. For the
analyses of anxiety expressions, the software package FaceR-
eader 7.037 was used to analyze the video-recordings made
during cardiac stress testing. Although this is a relatively novel
method, it has been validated and used in multiple research
settings.38-40 After taking a seat on the exercise bicycle (both
adenosine and exercise), the video-recordings started with
‘baseline’, approximately 1 minute before cardiac stress testing
actually began, and served as the baseline measure of facial
expression of anxiety. The three other time blocks during
cardiac stress testing were ‘start cardiac stress testing’ when
patients started exertion, ‘maximal cardiac stress testing’,
when heart rate was at peak level (or at 2 minutes after
adenosine injection), and ‘recovery’, when patients stopped
exertion and slowly recovered.
FaceReader Analysis of Video-Record-
ings FaceReader first synthesizes an artificial face model,
which describes the location of over 500 keypoints in the face
and the facial texture of the area entangled by these points.
Then, based on this, classification of the facial expressions is
done by an artificial neural network.41 Based on over 10.000
images, the network was trained to classify the six universal
emotions: anxiety, sadness, anger, surprise, happiness, and
disgust.42 Finally, scores of intensity of facial expressions are
computed on a continuous scale from 0 to 1, yielding the
percentage (0%-100%) of facial expression of anxiety. In
addition to the percentage of facial expression of anxiety, a
dichotomous measure (median split) of facial expression of
anxiety is used in statistical analyses.
Statistical Analysis
Data are presented as means ± standard deviation (SD)
for continuous variables and frequencies and percentages for
categorical variables, stratified by gender. Group comparisons
for categorical variables were examined using v2 tests and
continuous variables using independent t-tests, for the adeno-
sine and exercise protocols separately. Associations of
ischemia with trait and state anxiety and the interaction with
gender and age were examined using a two-way ANOVA with
a gender by (trait and state) anxiety interaction term, stratified
for two age groups: B 65 and C 65 years of age. Residual
analysis was performed to test for the assumptions of the two-
way ANOVA. Outliers were assessed by inspection of a
boxplot, and homogeneity of variances was assessed by
Levene’s test. SRS, SSS, and SDS were square root trans-
formed to account for outliers. The primary outcome measure
is ischemia, semi-quantitative operationalized as SDS, and
SSS, inferring diagnostic value.43 Hemodynamic measures
included HR, HRR, SBP, DBP, and LVEF. Statistical analyses
were performed using SPSS version 24.0 (SPSS Inc., Chicago,
Illinois), two-sided P values are reported and statistical
significance was set at P\ 0.05.
RESULTS
Patient Characteristics
Table 1 displays the patient characteristics. The
mean age of the sample was 66.8 ± 8.7 years. The mean
age for women was slightly lower (65.8 ± 8.5) than for
men (67.7 ± 8.8; P = .071). Men more often had a
previous MI (16% vs 5%, P = .006), PCI (34% vs 18%,
P = .002), and CABG (22% vs 5%, P\ .001) than
women. Women more often had no history of previously
known CAD compared to men (72% vs 50%, P = .001).
Gender Differences in Myocardial Ischemia
Myocardial ischemia was present in 107/291 (37%)
of the patients. Overall, women less often displayed
ischemia than men; 28% vs 39% (X2 = 6.98, P = .008),
and women had lower mean SRS (1.16 ± 2.83 vs
2.59 ± 5.0, P = .004), SSS (2.52 ± 4.74 vs
4.12 ± 6.16, P = .016), and TPD (2.09 ± 3.27 vs
3.18 ± 4.17, P = .016) values than men, and a similar
but non-significant difference was found for SDS
(1.45 ± 2.46 vs 1.84 ± 3.13, P = .253). We also
explored the interaction between gender and age as
related to ischemia, but no significant interactions
between gender and age were found with regard to
SRS, SSS, SDS and TPD values (all P[ .753).
Table 2 shows the analyses per cardiac stress testing
protocol (adenosine and bicycle exercise). Ischemia
occurred in 40% of the 203 patients undergoing the
adenosine protocol and 28% in the 88 patients under-
going the bicycle exercise protocol. During the
adenosine protocol, men displayed slightly more ische-
mia then women (46% vs 34%) but this difference was
not significant (P = .077) (Table 2). During the exercise
protocol, ischemia was more prevalent among men than
women (38% vs 16%, P = .022).
During the adenosine protocol, SSS was higher for
men compared to women (4.9 ± 6.9 vs 3.1 ± 5.2,
P = .046). TPD was higher for men only during the
exercise protocol (0.8 ± 1.6 vs 2.3 ± 3.1, P = .003). No
differences were found for typical anginal chest pain
between men and women for both protocols.
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Gender Differences in Trait and State
Anxiety
No significant gender differences were found for the
presence of trait anxiety (18% vs 18%, P = .883) with
similar total scores (women 5.48 ± 5.2 vs men
5.49 ± 5.6; P = .982). When comparing the sample by
age, no significant differences were found for the
presence of trait anxiety (23% (younger patients) vs
14% (older patients), P = .058). The interaction between
gender and age as related to trait anxiety was also not
significant (F(1, 270) = .633, P = .427, partial
g2 = .002)
Measures of state anxiety based on facial expression
revealed that no gender differences were found for
presence of state anxiety for all time blocks (baseline:
44% vs 38%, P = .270; start cardiac stress testing: 38%
vs 35%, P = .660; max cardiac stress testing: 47% vs
40%, P = .260; recovery: 45% vs 38%, P = .189). Mean
scores for each time block were also similar for men and
women (baseline: 2.94 vs 2.74, P = .552; start cardiac
stress testing: 2.52 vs 2.60, P = .796; max cardiac stress
testing: 3.26 vs 2.90, P = .449; recovery: 3.77 vs 3.33,
P = .267). The interaction between gender and age as
related to state anxiety was not significant for all time
blocks (all P[ .252).








Age (years) 65.8 ± 8.5 67.7 ± 8.8 .071
BMI (kg/m2) 28.9 ± 6.7 27.9 ± 4.5 .155
Smoking (yes) 16 (13%) 25 (16%) .451
Physical activity (sufficiently active)* 106 (84%) 135 (86%) .662
Hypertension 56 (49%) 72 (50%) .845
Hypercholesterolemia 56 (51%) 65 (47%) .471
Diabetes Mellitus 37 (23%) 28 (22%) .769
Familial risk (first degree family member) 82 (65%) 84 (53%) .043
Previous MI 7 (5%) 25 (16%) .006
Previous PCI 23 (18%) 55 (34%) .002
Previous CABG 6 (5%) 35 (22%) < .001
Reasons for referral
Examination of new or worsening symptoms (no previously
known CAD)
93 (72%) 81 (50%) .001
Examination of known CAD (recurring symptoms) 37 (29%) 77 (48%)
Preoperative cardiovascular risk assessment 0 (0%) 3 (2%)
Medication
Anticoagulants 83 (64%) 128 (80%) .003
ACE-ARB inhibitors 53 (41%) 90 (56%) .010
Beta-blocker 61 (47%) 92 (57%) .083
Calcium inhibitors 24 (19%) 54 (34%) .004
Diuretics 34 (26%) 34 (21%) .313
Statins 69 (53%) 113 (70%) .003
Nitrates 37 (29%) 58 (36%) .171
Diabetes medication 31 (19%) 24 (19%) .864
Antidepressants 18 (14%) 8 (5%) .008
Anxiety
Trait anxiety (GAD-7 mean score) 5.48 ± 5.2 5.49 ± 5.6 .982
Trait anxiety (GAD-7[10) 23 (18%) 26 (18%) .883
Data presented as mean ± standard deviation or number (%)
Bold values indicate P\ .05
Italic values indicate P\ .10
* Based on 30 minutes of daily moderate activity
BMI, Body Mass Index; MI, Myocardial Infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass
grafting; GAD, Generalized Anxiety Disorder
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Gender and Age Differences
in Hemodynamic Reactivity During Cardiac
Stress Testing
Women had a higher heart rate after 2 minutes of
adenosine injection (100.4 ± 16.8 bpm vs
90.8 ± 18.4 bpm, P\ .001) and HRR (40.9 ± 23.3 vs
30.7 ± 22.7, P = .002) than men. Baseline heart rate
was higher for women prior to the exercise protocol
(77.9 ± 12.7 bpm vs 71.7 ± 14.5 bpm, P = .039) and no
gender differences for peak heart rate or HRR during
exercise were found. No significant differences in blood
pressure during rest or peak were found between men
and women for both protocols (Table 2).
As expected, LVEF values were higher in women
than men during both rest (64.2% ± 11.8% vs
53.7% ± 11.6%, P\ .001) and cardiac stress testing
(62.4% ± 11.1% vs 50.5% ± 11.2%, P\ .001). LVEF
decreased during the adenosine protocol for women
(64.9% ± 10.9% to 62.5% ± 10.8%, P = .002) and men
(53.3% ± 11.6% to 51.1% ± 10.9%, P =\ .001). Dur-
ing the exercise protocol, LVEF significantly increased
for men (55.5% ± 10.3% to 57.6% ± 11.1%, P = .018),

















SDS score 1.8 ± 2.7 2.0 ± 3.4 .719 0.6 ± 1.3 1. 5 ± 2.3 .013
SSS score 3.1 ± 5.2 4.9 ± 6.9 .046 1.0 ± 3.0 2.5 ± 3.5 .037
Ischemia based on SDS
score C 2
31 (34%) 51 (46%) .077 6 (16%) 19 (38%) .022
TPD 2.6 ± 3.6 3.6 ± 4.5 .101 0.8 ± 1.6 2.3 ± 3.1 .003
Typical anginal chest pain
present
43 (47%) 38 (34%) .070 8 (21%) 8 (16%) .543
LVEF
LVEF rest (%) 64.2 ± 11.8 53.7 ± 11.6 < .001 68.2 ± 9.7 55.5 ± 10.2 < .001
LVEF stress (%) 62.4 ± 11.1 50.5 ± 11.2 < .001 68.4 ± 9.0 57.2 ± 11.3 < .001
EDV rest (ml) 73.1 ± 35.4 105.8 ± 37.9 < .001 64.2 ± 15.5 102.3 ± 27.6 < .001
ESV rest (ml) 30.1 ± 27.9 52.0 ± 33.2 < .001 21.5 ± 11.6 47.2 ± 19.9 < .001
EDV post-stress (ml) 74.6 ± 24.9 113.5 ± 47.1 < .001 63.1 ± 18.1 98.5 ± 29.1 < .001
ESV post-stress (ml) 30.2 ± 18.7 59.7 ± 41.2 < .001 21.4 ± 11.6 44.3 ± 20.8 < .001
Diastolic blood pressure (DBP)
Baseline (mmHg) 79.3 ± 13.0 78.7 ± 12.9 .755 82.0 ± 8.7 79.4 ± 12.9 .281
Peak (mmHg) 73.6 ± 14.8 76.2 ± 12.3 .183 84.4 ± 21.6 90.4 ± 18.5 .163
Systolic blood pressure (SBP)
Baseline (mmHg) 133.3 ± 26.2 127.3 ± 23.1 .091 131.7 ± 21.6 128.5 ± 15.9 .426
Peak (mmHg) 141.1 ± 29.9 139.86 ± 22.7 .729 165.7 ± 33.0 178.3 ± 29.2 .062
Heart rate
Baseline (bpm) 72.1 ± 12.1 70.0 ± 11.7 .208 77.9 ± 12.7 71.7 ± 14.5 .039
Peak (bpm) 100.4 ± 16.8 90.8 ± 18.4 < .001 128.5 ± 24.0 135.8 ± 20.1 .122
HRR (%) 40.9 ± 23.3 30.7 ± 22.7 .002 67.3 ± 34.5 96.3 ± 48.9 .002
State anxiety
Rest 2.8 ± 3.0 2.8 ± 2.6 .939 2.5 ± 0.4 3.3 ± 2.6 .165
Stress 3.1 ± 3.1 3.0 ± 3.8 .923 2.6 ± 2.2 3.8 ± 5.9 .192
Data presented as mean ± standard deviation or number (%)
Bold values indicate P\ .05
Italic values indicate P\ .10
SDS, summed difference score; SSS, summed stress score; TPD, total perfusion deficit; LVEF, left ventricular ejection fraction; EDV,
end diastolic volume; ESV, end systolic volume; DBP, diastolic blood pressure; SBP, systolic blood pressure; HRR, heart rate
response
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but not for women (68.2% ± 9.7% to 68.4% ± 9.0%,
P = .835).
When examining age groups, patients under
65 years in the adenosine protocol had a significantly
higher peak heart rate (at 2 minutes after adenosine
injection) than patients older than 65 years
(100.3 ± 16.0 vs 92.4 ± 18.8 bpm, P = .002). Patients
older than 65 years had a higher rest systolic blood
pressure than patients younger than 65 years
(133.9 ± 25.2 vs 122.5 ± 22.0 mmHg, P = .001). In
the exercise protocol, patients under 65 years had a
significantly higher peak heart rate than patients older
than 65 years (140.4 ± 19.4 vs 125.1 ± 22.0 bpm,
P = .001). No significant differences in blood pressure
were found between age groups. No significant differ-
ences were found in LVEF for both protocols.
Trait Anxiety and Hemodynamic Reactivity
Patients with high trait anxiety in the adenosine
protocol (n = 41) had significantly higher baseline heart
rate (74.0 ± 10.0 vs 70.1 ± 12.1 bpm, P = .038) and
peak heart rate (102.9 ± 17.3 vs 93.4 ± 18.2 bpm,
P = .003) than patients with low anxiety (n = 152,
reported numbers smaller due to 10 missing values for
GAD-7). Patients with high trait anxiety (n = 8) in the
exercise protocol had a significantly lower baseline
LVEF (53.4% ± 7.9% vs 62.3 ± 11.4%, P = .025) than
patients with low trait anxiety (n = 73, reported numbers
smaller due to seven missing values for GAD-7).
State Anxiety and Hemodynamic Reactivity
During start cardiac stress testing, patients with high
state anxiety during the adenosine protocol (n = 76) had
a lower systolic blood pressure than patients with low
Figure 1. Summed Difference Score (SDS, square root transformed) stratified for trait anxiety
(high/low), gender and age groups. The presence of ischemia is presented in the bar graphs as % per
subgroup.
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state anxiety during cardiac stress testing (n = 127)
(125.5 ± 20.5 vs 132.8 ± 26.7 mmHg, P = .032). No
other differences in hemodynamic reactivity were found
for patients undergoing the adenosine protocol. In the
exercise protocol, patients with high state anxiety during
recovery (n = 43) had a higher peak LVEF than patients
with low state anxiety (n = 39) (64.7% ± 11% vs
59.2% ± 11.9%, P = .030). No other differences were
found in hemodynamic reactivity for patients in the
exercise protocol.
Trait Anxiety and Ischemia
There was no significant overall association
between trait anxiety with inducibility of ischemia,
SSS, SDS, or TPD values (all P[ .221 and partial
g2\ .006). There were also no gender-by-trait anxiety
interactions for these measures (P values[ .217; partial
g2\ .003).
However, as shown in Figures 1 and 2, significant
interaction effects were found between gender and trait
anxiety when stratifying by age. For individu-
als B 65 years, the gender x trait anxiety interactions
were significant for SDS (F(1, 4) = 5.73, P = .019,
partial g2 = .053), SSS (F(1,10) = 6.50, P = .012, par-
tial g2 = .060), and TPD (F(1, 26) = 5.71, P = .019,
partial g2 = .053), for patients under 65 years of age. For
women with high trait anxiety the mean SDS was 0.65
(95% CI: 0.14-1.15) higher than in women with low trait
anxiety. Similarly, the mean SSS was 0.80 (95% CI:
0.03-1.57) higher than women with low anxiety scores,
and the mean TPD was 1.91 (95% CI: 0.59-3.23) higher
in women with high vs low trait anxiety. These
associations with trait anxiety were not observed in
men (Figures 1 and 2).
For patients[ 65 years, a significant interaction
effect was found for gender with trait anxiety for TPD
only (F(1, 80) = 4.05, P = .046, partial g2 = .025). For
patients with high trait anxiety, the mean TPD was 4.71
(95% CI 0.96-8.46) higher for men than for women,
whereas other subgroup comparisons were not
significant.
Figure 2. Summed Stress Score (SSS, square root transformed) stratified for trait anxiety (high/
low), gender and age groups. The presence of ischemia presented in the bar graphs as % per
subgroup.
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State Anxiety and Ischemia
A two-way ANOVA showed that the interaction
effect between state anxiety and gender for SSS, SDS,
and TPD was not statistically significant for either of the
four time blocks (baseline, start cardiac stress testing,
max cardiac stress testing, and recovery) during cardiac
stress testing (all P values C .071 and partial g2\ .023)
for both patients under and over 65 years.
DISCUSSION
The present study examines whether anxiety plays a
role in the gender differences in hemodynamic reactivity
and inducible ischemia during cardiac stress testing. The
first hypothesis was not confirmed, as men and women
did not differ on overall trait and state anxiety. The
second hypothesis was confirmed, since women had
higher heart rate responses to cardiac stress testing when
undergoing the adenosine protocol and, overall, a higher
heart rate response was associated with high trait
anxiety. For the third hypotheses, we found that mea-
sures of ischemia (SDS and SSS), albeit low in each
subgroup, were significantly higher in women with high
trait anxiety, but only in patients younger than 65 years
of age.
Gender differences during cardiac stress testing
were examined for both the adenosine and exercise
protocol. For the adenosine protocol, the peak heart rate
and HRR were significantly higher in women compared
to men. This difference was not observed during the
exercise protocol, in which peak heart rate was higher
for men and no gender differences in HRR were found.
Consistent with these results, previous studies deter-
mined gender and age as independent factors associated
with HR responses.44,45 Mechanisms for this gender
difference are not yet fully clear, but research suggests
that women exhibit higher parasympathetic stimulation
of the heart, which is ultimately protective during
periods of increased cardiac stress.46 However, no
marked gender differences were found for SBP and
DBP during baseline and peak for both protocols.
Consistent with earlier studies, SBP was slightly blunted
during adenosine in women, but not in men.47 A
significantly higher LVEF was observed in women
compared to men for both protocols which is consistent
with previous findings.48 Reduced LVEF has been
associated with inducibility of myocardial ischemia,49
which may partially explain the overall higher preva-
lence of ischemia in men than women.
For patients younger than 65 years, a significant
interaction effect was found between trait anxiety, but
not state anxiety, and gender. Being female, younger
than 65 years, and having high trait anxiety was
associated with a significantly higher SSS, SDS, and
TPD compared to men. This finding was not observed in
patients of 65 years and older. The observed state versus
trait anxiety contrast in association with ischemia is
consistent with earlier findings.26,50 These two studies,
however, were conducted with a healthy elderly (male)
patient sample and a cardiac syndrome X patient sample,
respectively, suggesting that trait anxiety is a recurring
significant factor in both patients with and without
cardiac history and studies with different cardiac out-
comes. In the study by Paine and colleagues,25 trait
anxiety in women with no CAD history was significantly
related to increased ischemia extent compared to women
without anxiety, which is comparable to the findings by
Vermeltfoort and colleagues,26 but in the study of Paine,
state anxiety was not examined. In the present study,
both trait and state anxiety were examined in relation to
ischemia and groups were stratified for age, as is done in
the study by Gebhard and colleagues,21 which concludes
that younger women with ischemia have a stronger
hemodynamic response to adenosine stress testing than
men, a finding that was partly confirmed in our study
when comparing women to men.
Consequently, when examining previous studies,
our finding that trait anxiety is related to myocardial
ischemia in younger women could possibly be attributed
to increased sympathetic nervous system activity inher-
ent to anxiety.51 Increased sympathetic nervous system
activity could result in an increased presence of
ischemia through increases in heart rate and vasocon-
striction.52 However, increased sympathetic nervous
system activity is beyond the scope of the present study
and requires additional research. In addition, it is unclear
whether this rationale would be more applicable to trait
anxiety or state anxiety.
The present study had some strengths and limita-
tions that should be taken into consideration. Limitations
include the relatively small patient sample and the cross-
sectional design, making discussions on causality only
speculative. The incorporation of a validated question-
naire to measure trait anxiety can be considered a
strength of this study. A unique aspect is the measure-
ment of state anxiety with facial expression recognition
software during cardiac stress testing. Because of the
transient nature of cardiac stress testing, it should be
linked with a transient measure of facial expressions of
emotions to optimally reflect the dynamic association
between emotions and ischemia.53 The low intensity of
detected state anxiety during cardiac stress testing for
men and women (under 10%), could account for the
non-significant reported findings for state anxiety in this
study.
When evaluating the gender differences in patient
characteristics, it was observed that men more often had
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an elaborate cardiac history compared to women, which
is consistent with previous studies.54 Reasons account-
ing for this difference are discussed with increasing
attention for psychological factors.55,56 Furthermore, no
significant differences in typical anginal chest pain
during cardiac stress testing were found for men and
women in both protocols. This study also confirms the
trait and state anxiety contrast reported in previous
studies and suggests that high trait anxiety is an
important factor to take into account in women with
myocardial ischemia. Larger studies with more sociode-
mographic variation in the patient groups are needed to
further clarify the risk of anxiety in patients with
myocardial ischemia.
To conclude, this study shows that female patients
younger than 65 years of age with high trait anxiety
have increased SDS, SSS, and TPD following cardiac
stress testing compared with men and patients older than
65 years. Thus, the implications of psychological con-
structs on cardiac health are intertwined with gender and
age. This interplay is worthy of further investigation and
larger observational and intervention studies in patients
who are at high risk of myocardial ischemia and adverse
long-term cardiovascular prognosis.
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